Key Metrics
CiteScore 

2.5
Impact Factor 

< 5
SJR 

Q3Virology

SNIP 

1.02
Recommended pre-submission checks
Powered by 

Topics Covered on AIDS Research and Therapy
AIDS Research and Therapy Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | BMC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2290 | USD 2790 | GBP 1890 |
| Publication Time | 16 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC0 |
| OA statement | Visit website |
View less
Planning to publish in AIDS Research and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in AIDS Research and Therapy
From inflammatory to reconstitution: a longitudinal exploratory study of cytokine dynamics in HIV/TB co-infected patients.
- 20 Jul 2026
- AIDS research and therapy
Burden and determinants of hyperuricemia among adults living with HIV at Lira Regional Referral Hospital in Uganda : a cross-sectional study.
- 18 Jul 2026
- AIDS research and therapy
Pretreatment HIV-1 drug resistance and molecular subtype characteristics among newly diagnosed individuals in Guangxi, China.
- 17 Jul 2026
- AIDS research and therapy
Shifting neuropsychiatric diagnoses across the antiretroviral therapy era at an urban Ugandan HIV centre: a descriptive analysis of routinely collected electronic health records, 2017 to April 2026.
- 17 Jul 2026
- AIDS research and therapy
B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.
- 16 Jul 2026
- AIDS research and therapy
Effectiveness and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV (PWH) in routine clinical practice in Türkiye: 12-month outcomes from the KLIMIK HIV-TR cohort.
- 15 Jul 2026
- AIDS research and therapy
From inflammatory to reconstitution: a longitudinal exploratory study of cytokine dynamics in HIV/TB co-infected patients.
- 20 Jul 2026
- AIDS research and therapy
Burden and determinants of hyperuricemia among adults living with HIV at Lira Regional Referral Hospital in Uganda : a cross-sectional study.
- 18 Jul 2026
- AIDS research and therapy
Pretreatment HIV-1 drug resistance and molecular subtype characteristics among newly diagnosed individuals in Guangxi, China.
- 17 Jul 2026
- AIDS research and therapy
Shifting neuropsychiatric diagnoses across the antiretroviral therapy era at an urban Ugandan HIV centre: a descriptive analysis of routinely collected electronic health records, 2017 to April 2026.
- 17 Jul 2026
- AIDS research and therapy
B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.
- 16 Jul 2026
- AIDS research and therapy
Effectiveness and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV (PWH) in routine clinical practice in Türkiye: 12-month outcomes from the KLIMIK HIV-TR cohort.
- 15 Jul 2026
- AIDS research and therapy